Shares of Humana Inc. are poised to rebound after a rough performance in 2012, thanks in part to growth prospects for the health insurer's Medicare Advantage plans, according to a Bernstein Research analyst.
The Louisville, Ky., company's stock sank 22 percent last year to close at $68.63. In contrast, the Standard & Poor's 500 index rose more than 13 percent.
Analyst Ana Gupte said in a Thursday morning research note she has a $95 price target on the stock, and she expects 2013 earnings of $9.20 per share, which far exceeds the company's initial forecast for earnings of between $7.60 and $7.80 per share. The insurer expects 2012 earnings of $7.25 to $7.35 per share.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
